NVCT
Nuvectis Pharma Inc
20.20$
-6.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.7% | +6.2% | -2.6% | -8.2% | -1.6% | +19.9% | +26.5% | -15.8% | +1.3% | +25.3% | -7.6% | – | |
| – | +3.2% | -195.6% | – | +304.1% | +347.8% | -107.9% | – | +22.2% | +23.4% | -224.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.4% | +412.1% | -64.4% | -12.9% | +162.8% | +304.9% | -98.1% | +4,340.2% | -98.7% | -95.8% | +22,200.0% | – | |
| – | – | – | -498.8% | – | – | +730.7% | -127.1% | – | -144.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.